» Articles » PMID: 23658245

Genomic Diversity and Fitness of E. Coli Strains Recovered from the Intestinal and Urinary Tracts of Women with Recurrent Urinary Tract Infection

Overview
Journal Sci Transl Med
Date 2013 May 10
PMID 23658245
Citations 92
Authors
Affiliations
Soon will be listed here.
Abstract

Urinary tract infections (UTIs) are common in women, and recurrence is a major clinical problem. Most UTIs are caused by uropathogenic Escherichia coli (UPEC). UPEC are generally thought to migrate from the gut to the bladder to cause UTI. UPEC form specialized intracellular bacterial communities in the bladder urothelium as part of a pathogenic mechanism to establish a foothold during acute stages of infection. Evolutionarily, such a specific adaptation to the bladder environment would be predicted to result in decreased fitness in other habitats, such as the gut. To examine this prediction, we characterized 45 E. coli strains isolated from the feces and urine of four otherwise healthy women with recurrent UTI. Multilocus sequence typing and whole genome sequencing revealed that two patients maintained a clonal population in both these body habitats throughout their recurrent UTIs, whereas the other two exhibited a wholesale shift in the dominant UPEC strain colonizing both sites. In vivo competition studies in mouse models, using isolates taken from one of the patients with a wholesale population shift, revealed that the strain that dominated her last UTI episode had increased fitness in both the gut and the bladder relative to the strain that dominated in preceding episodes. Increased fitness correlated with differences in the strains' gene repertoires and carbohydrate and amino acid utilization profiles. Thus, UPEC appear capable of persisting in both the gut and urinary tract without a fitness trade-off, emphasizing the need to widen our consideration of potential reservoirs for strains causing recurrent UTI.

Citing Articles

Canine urothelial cell model to study intracellular bacterial community development by uropathogenic Escherichia coli.

Gilbertie J, Sheahan B, Vaden S, Jacob M PLoS One. 2025; 20(1):e0316834.

PMID: 39787183 PMC: 11717241. DOI: 10.1371/journal.pone.0316834.


Intestinal microbiology and urinary tract infection associated risk in long-term aged care residents.

Miller S, Carpenter L, Taylor S, Wesselingh S, Choo J, Shoubridge A Commun Med (Lond). 2024; 4(1):164.

PMID: 39152271 PMC: 11329762. DOI: 10.1038/s43856-024-00583-y.


fitness of gene-dependent sulfonamide-resistant in the mammalian gut.

Jiang H, Dong Y, Jiao X, Tang B, Feng T, Li P mSystems. 2024; 9(9):e0083624.

PMID: 39140732 PMC: 11406977. DOI: 10.1128/msystems.00836-24.


Cataloging the phylogenetic diversity of human bladder bacterial isolates.

Du J, Khemmani M, Halverson T, Ene A, Limeira R, Tinawi L Genome Biol. 2024; 25(1):75.

PMID: 38515176 PMC: 10958879. DOI: 10.1186/s13059-024-03216-8.


Mapping niche-specific two-component system requirements in uropathogenic .

Brannon J, Reasoner S, Bermudez T, Comer S, Wiebe M, Dunigan T Microbiol Spectr. 2024; 12(4):e0223623.

PMID: 38385738 PMC: 10986536. DOI: 10.1128/spectrum.02236-23.


References
1.
. Structure, function and diversity of the healthy human microbiome. Nature. 2012; 486(7402):207-14. PMC: 3564958. DOI: 10.1038/nature11234. View

2.
Hunstad D, Justice S . Intracellular lifestyles and immune evasion strategies of uropathogenic Escherichia coli. Annu Rev Microbiol. 2010; 64:203-21. DOI: 10.1146/annurev.micro.112408.134258. View

3.
Zdziarski J, Svanborg C, Wullt B, Hacker J, Dobrindt U . Molecular basis of commensalism in the urinary tract: low virulence or virulence attenuation?. Infect Immun. 2007; 76(2):695-703. PMC: 2223460. DOI: 10.1128/IAI.01215-07. View

4.
Mysorekar I, Hultgren S . Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc Natl Acad Sci U S A. 2006; 103(38):14170-5. PMC: 1564066. DOI: 10.1073/pnas.0602136103. View

5.
Luangtongkum T, Shen Z, Seng V, Sahin O, Jeon B, Liu P . Impaired fitness and transmission of macrolide-resistant Campylobacter jejuni in its natural host. Antimicrob Agents Chemother. 2011; 56(3):1300-8. PMC: 3294946. DOI: 10.1128/AAC.05516-11. View